# Fidia Farmaceutici

Italian Fidia won FDA approval for HYMOVIS ONE, a single-injection hyaluronan therapy for knee osteoarthritis launched at AAOS 2026, and runs the established Hyalgan viscosupplementation line, while EU R&D develops HA–recombinant-collagen combination implants for tissue regeneration.

Source: https://en.bioecon.ru/companies/fidia-farmaceutici/
Updated: 2026-06-28

- Country: Italy

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | €538.3 million (2025-12-31) | https://fidiapharma.us/newsroom/fidia-farmaceutici-revenues-to-reach-e538-million-in-2025-up-5-5-y-y/, https://www.corriere.it/economia/finanza/26_aprile_30/fidia-farmaceutici-fatturato-2025-a-538-3-milioni-5-5-salgono-i-margini-2f9b8ae6-c942-4967-b67a-244f933daxlk.shtml, https://www.fidiapharma.it/newsroom/fidia-farmaceutici-ricavi-raggiungono-e538-milioni-in-2025/ |
| Headcount | 1,708 employees (2025-12-31) | https://fidiapharma.us/newsroom/fidia-farmaceutici-revenues-to-reach-e538-million-in-2025-up-5-5-y-y/, https://www.corriere.it/economia/finanza/26_aprile_30/fidia-farmaceutici-fatturato-2025-a-538-3-milioni-5-5-salgono-i-margini-2f9b8ae6-c942-4967-b67a-244f933daxlk.shtml, https://www.fidiapharma.it/newsroom/fidia-farmaceutici-ricavi-raggiungono-e538-milioni-in-2025/ |
| Regulatory approval | FDA premarket approval (PMA) for HYMOVIS ONE (2025-04-09) | https://fidiapharma.us/newsroom/fidia-introduces-hymovis-one-a-leading-edge-hyaluronan-at-the-aaos-2026-annual-meeting-in-new-orleans-la/, https://www.fidiapharma.com/newsroom/advancing-joint-care-worldwide-hymovis-one-receives-fda-approval/ |
| Production site | Abano Terme (Padua), Noto (Syracuse), Paderno Dugnano (Milan), and Monte Giberto (Fermo) | https://www.fidiapharma.com/our-innovation/sites/, https://www.fidiapharma.com/wp-content/uploads/2025/05/Fidia-Consolidated-financial-statements-2024.pdf |
| Capacity | Inaugurated a new biological medicines production unit at Abano Terme headquarters to expand capacity (2025-06-01) | https://fidiapharma.us/newsroom/fidia-farmaceutici-revenues-to-reach-e538-million-in-2025-up-5-5-y-y/, https://www.fidiapharma.it/newsroom/fidia-farmaceutici-ricavi-raggiungono-e538-milioni-in-2025/ |
| Certification | ISO 9001, ISO 13485, ISO 14001, ISO 22716, and GMP certifications across various production sites (2024-12-31) | https://www.fidiapharma.com/our-innovation/sites/, https://www.fidiapharma.com/wp-content/uploads/2025/05/Fidia-Consolidated-financial-statements-2024.pdf |

Independent sources: corriere.it, fidiapharma.com, fidiapharma.it, fidiapharma.us

## Technologies

- [Biosynthetic hyaluronic acid](https://en.bioecon.ru/technology/biosynthetic-hyaluronic-acid/)